Oncolytic Reovirus and Immune Checkpoint Inhibition as a Novel Immunotherapeutic Strategy for Breast Cancer

Ahmed Mostafa, Daniel E. Meyers, Chandini M. Thirukkumaran, +6

Cancers

The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer

Satbir Thakur, Haocheng Li, Angela Chan, +5

PLoS ONE

ING1 induces apoptosis through direct effects at the mitochondria

Pinaki Bose, Satbir Thakur, Subhash Thalappilly, +5

Cell Death and Disease

ApoptosisCell DeathCancer BiologyTumor BiologyOxidative Stress +16

ING1 and 5-Azacytidine Act Synergistically to Block Breast Cancer Cell Growth

Satbir Thakur, Xiaolan Feng, Zhong Qiao Shi, +5

PLoS ONE

Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma

Keith A. Lawson, Ahmed Mostafa, Zhong Qiao Shi, +6

Clinical Cancer Research

ImmunologyImmunoeditingImmunotherapeuticsAntiviral DrugImmunotherapy +22

Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model

Chandini M. Thirukkumaran, Zhong Qiao Shi, Gerard J. Nuovo, +14

Blood Advances

ImmunologyImmunoeditingImmunotherapyBortezomib SynergyTumor Biology +19

Src Regulates the Activity of the ING1 Tumor Suppressor

Lisa Yu, Satbir Thakur, Rebecca Y. Y. Leong-Quong, +4

PLoS ONE

Cancer BiologyIng1 Tumor SuppressorTumor BiologyCell RegulationReceptor Tyrosine Kinase +14

ING3 protein expression profiling in normal human tissues suggest its role in cellular growth and self-renewal

Arash Nabbi, Amal Almami, Satbir Thakur, +3

European Journal of Cell Biology

Cellular GrowthSignal TransductionDevelopmental BiologyNormal Human TissuesProtein Expression +10

Reduced ING1 levels in breast cancer promotes metastasis

Satbir Thakur, Arvind K. Singla, Jie Chen, +7

Oncotarget

Stromal ING1 expression induces a secretory phenotype and correlates with breast cancer patient survival

Satbir Thakur, Arash Nabbi, Alexander C. Klimowicz, +1

Molecular Cancer